David V. Gauvin; Joshua Yoder; Rachel L. Tapp; Phaedra I. Cole; Phaedra I. Cole. Defining “Best Practices” for Critical Endpoints in Preclinical Screening of New Chemical Entities for Ototoxicity Liability. OOJ 2016, 2, 58-69.